Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
|
Avastin and Other Emerging Agents Will Drive the Glioma Drug Market to More Than $1.8 Billion in 2017Monday 8th of December 2008 8:00BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
 Browse other news from this organisation: Decision Resources Related Web-Links(If any, Generated Automatically)
Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
